Elfabrio 20 mg/10 mL (2 mg/mL) injection Images
Generic Name: pegunigalsidase alfa
This medication has been identified as Elfabrio 20 mg/10 mL (2 mg/mL) injection. It is supplied by Chiesi USA, Inc.
Elfabrio is used in the treatment of Fabry Disease and belongs to the drug class lysosomal enzymes. Elfabrio 20 mg/10 mL (2 mg/mL) injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Elfabrio
- Generic Name
- pegunigalsidase alfa
- Strength
- 20 mg/10 mL (2 mg/mL) injection
- Availability
- Prescription only
- Drug Class
- Lysosomal enzymes
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Chiesi USA, Inc.
- National Drug Code (NDC)
- 10122-0160
See also:
Fabrazyme
Fabrazyme (agalsidase beta) is used in the treatment of Fabry disease. Includes Fabrazyme side ...
Aldurazyme
Aldurazyme is used to treat the symptoms of Hurler syndrome. Learn about side effects, interactions ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Brineura
Brineura (cerliponase alfa) is used to slow the loss of ability to crawl or walk in children and ...
Cerezyme
Cerezyme is a man-made form of an enzyme that occurs naturally in the body. It is used as an enzyme ...
Elaprase
Elaprase is an IV infusion used to treat some of the symptoms of a genetic condition called ...
Elelyso
Elelyso (taliglucerase alfa) is used to treat Gaucher disease. Includes Elelyso side effects ...
More about Elfabrio (pegunigalsidase alfa)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: lysosomal enzymes
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.